4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0000905148-25-001900
President and CEO gave up 19,904 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Blume-Jensen Peter President and CEO | 2025-05-21 | Shares withheld for taxes | −19,904 | $1.15 | $22,890 | 2,206,111 | D: show line 1 in the form |
Loading xslF345X05/form4.xml…